Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Net Sales
459.92
344.45
Other Operating Income
0.00
0.00
Total Operating income
459.92
344.45
Raw Material Cost
198.36
145.25
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-34.92
-40.22
Employee Cost
41.37
27.41
Power Cost
0.00
0.00
Manufacturing Expenses
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
Other Expenses
95.80
80.84
Total Expenditure (Excl Depreciation)
300.62
213.27
Operating Profit (PBDIT) excl Other Income
159.30
131.18
Other Income
22.16
5.57
Operating Profit (PBDIT)
181.46
136.75
Interest
5.16
3.99
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
176.30
132.76
Depreciation
10.92
7.77
Profit Before Tax
165.39
124.99
Tax
39.64
30.44
Provisions and contingencies
0.00
0.00
Profit After Tax
125.75
94.54
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
125.75
94.54
Share in Profit of Associates
0.00
0.00
Minority Interest
-1.25
0.00
Other related items
0.00
0.00
Consolidated Net Profit
124.01
94.54
Equity Capital
11.29
9.72
Face Value
1.0
1.0
Reserves
0.00
0.00
Diluted Earnings per share
4.29
0.27
Operating Profit Margin (Excl OI)
34.64%
38.08%
Gross Profit Margin
38.33%
38.54%
PAT Margin
27.34%
27.45%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 2.56%
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 30.68%
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 5.08%
Interest
YoY Growth in nine months ended Dec 2025 is 26.54%
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Sudeep Pharma With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
459.92
0
459.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
459.92
0
459.92
Raw Material Cost
198.36
0
198.36
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-34.92
0
-34.92
Employee Cost
41.37
0
41.37
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
95.80
0.00
95.80
Total Expenditure (Excl Depreciation)
300.62
0
300.62
Operating Profit (PBDIT) excl Other Income
159.30
0.00
159.30
Other Income
22.16
0
22.16
Operating Profit (PBDIT)
181.46
0
181.46
Interest
5.16
0
5.16
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
176.30
0
176.30
Depreciation
10.92
0
10.92
Profit Before Tax
165.39
0
165.39
Tax
39.64
0
39.64
Provisions and contingencies
0.00
0
0.00
Profit After Tax
125.75
0
125.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
125.75
0
125.75
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-1.25
0
-1.25
Other related items
0.00
0.00
0.00
Consolidated Net Profit
124.01
0
124.01
Equity Capital
11.29
0
11.29
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
38.33%
0.00%
0.00
38.33%
PAT Margin
27.34%
0.00%
0.00
27.34%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 258.34 Cr
in Dec 2025Figures in Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 81.82 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 90.88 Cr
in Dec 2025Figures in Cr
Nine Monthly - Interest
Interest 4.10 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.18%
in Dec 2025Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
